NEW YORK – Gene editing company Metagenomi emerged from stealth mode on Thursday, announcing that it has completed a $65 million Series A financing round.
The round was led by Leaps by Bayer and Humboldt Fund. Other investors included Sozo Ventures, Agent Capital, InCube Ventures, and HOF Capital.